{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T23:08:52Z","timestamp":1767654532831,"version":"3.48.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172283"],"award-info":[{"award-number":["82172283"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Antibiot"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1038\/s41429-025-00869-w","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T03:24:36Z","timestamp":1759980276000},"page":"30-40","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Antibacterial effects of BB-Cl-Amidine against multidrug-resistant Gram-positive pathogens via membrane disruption"],"prefix":"10.1038","volume":"79","author":[{"given":"Zhenfeng","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junhua","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jintuan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Congcong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhijian","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guiqiu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,9]]},"reference":[{"key":"869_CR1","doi-asserted-by":"publisher","first-page":"677","DOI":"10.3390\/toxins13100677","volume":"13","author":"N Ahmad-Mansour","year":"2021","unstructured":"Ahmad-Mansour N, Loubet P, Pouget C, et al. Staphylococcus aureus toxins: an update on their pathogenic properties and potential treatments[J]. Toxins. 2021;13:677.","journal-title":"Toxins"},{"key":"869_CR2","doi-asserted-by":"publisher","first-page":"e606","DOI":"10.1016\/S2666-5247(24)00040-5","volume":"5","author":"P Piewngam","year":"2024","unstructured":"Piewngam P, Otto M. Staphylococcus aureus colonization and strategies for decolonization. Lancet Microbe. 2024;5:e606\u201318.","journal-title":"Lancet Microbe"},{"key":"869_CR3","doi-asserted-by":"publisher","first-page":"2002094","DOI":"10.2807\/1560-7917.ES.2021.26.46.2002094","volume":"26","author":"C Gagliotti","year":"2021","unstructured":"Gagliotti C, H\u00f6gberg LD, Billstr\u00f6m H, et al. Staphylococcus aureus bloodstream infections: diverging trends of methicillin-resistant and methicillin-susceptible isolates, EU\/EEA, 2005 to 2018[J]. Eurosurveillance. 2021;26:2002094.","journal-title":"Eurosurveillance"},{"key":"869_CR4","doi-asserted-by":"crossref","unstructured":"Chen H, Song S, Cui R, Feng YW, Ge P. Global trends in staphylococcus aureus-related lower respiratory infections from 1990 to 2021: findings from the 2021 global burden of disease report. Eur J Clin Microbiol Infect Dis. 2025;44:1455\u201369.","DOI":"10.1007\/s10096-025-05111-x"},{"key":"869_CR5","doi-asserted-by":"crossref","unstructured":"Liang J, Hu Y, Fu M, et al. Resistance and molecular characteristics of methicillin-resistant Staphylococcus aureus and heterogeneous vancomycin-intermediate Staphylococcus aureus[J]. Infect Drug Resist. 2023;16:379\u201388.","DOI":"10.2147\/IDR.S392908"},{"key":"869_CR6","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1093\/jac\/dkac411","volume":"78","author":"B Youenou","year":"2023","unstructured":"Youenou B, Martins Simoes P, Tristan A, et al. Linezolid resistance: detection of the cfr (B) gene in French clinical MRSA strains[J]. J Antimicrob Chemother. 2023;78:445\u20139.","journal-title":"J Antimicrob Chemother"},{"key":"869_CR7","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.jinf.2011.07.001","volume":"63","author":"C Garrigos","year":"2011","unstructured":"Garrigos C, Murillo O, Euba G, et al. Efficacy of tigecycline alone and with rifampin in foreign-body infection by methicillin-resistant Staphylococcus aureus[J]. J Infect. 2011;63:229\u201335.","journal-title":"J Infect"},{"key":"869_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jac\/dkx349","volume":"73","author":"M Heidary","year":"2018","unstructured":"Heidary M, Khosravi AD, Khoshnood S, et al. Daptomycin[J]. J Antimicrob Chemother. 2018;73:1\u201311.","journal-title":"J Antimicrob Chemother"},{"key":"869_CR9","first-page":"178","volume":"4","author":"JL Lister","year":"2014","unstructured":"Lister JL, Horswill AR. Staphylococcus aureus biofilm: recent developments in biofilm dispersal[J]. Front Cell Microb. 2014;4:178.","journal-title":"Front Cell Microb"},{"key":"869_CR10","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01011-21","volume":"12","author":"JLE Willett","year":"2021","unstructured":"Willett JLE, Dale JL, Kwiatkowski LM, et al. Comparative biofilm assays using Enterococcus faecalis OG1RF identify new determinants of biofilm formation. mBio. 2021;12:e0101121.","journal-title":"mBio"},{"key":"869_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41522-019-0099-0","volume":"5","author":"JLE Willett","year":"2019","unstructured":"Willett JLE, Ji MM, Dunny GM. Exploiting biofilm phenotypes for functional characterization of hypothetical genes in Enterococcus faecalis. NPJ Biofilms Microbiomes. 2019;5:23.","journal-title":"NPJ Biofilms Microbiomes"},{"key":"869_CR12","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1099\/mic.0.2007\/013292-0","volume":"154","author":"M Vergara-Irigaray","year":"2008","unstructured":"Vergara-Irigaray M, Maira-Litran T, Merino N, et al. Wall teichoic acids are dispensable for anchoring the PNAG exopolysaccharide to the Staphylococcus aureus cell surface[J]. Microbiology. 2008;154:865\u201377.","journal-title":"Microbiology"},{"key":"869_CR13","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1136\/annrheumdis-2014-205365","volume":"74","author":"JS Knight","year":"2015","unstructured":"Knight JS, Subramanian V, O\u2019Dell AA, et al. Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin, and vascular disease in lupus-prone MRL\/lpr mice[J]. Annals Rheum Dis. 2015;74:2199\u2013206.","journal-title":"Annals Rheum Dis"},{"key":"869_CR14","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12950-022-00317-8","volume":"19","author":"A Stachowicz","year":"2022","unstructured":"Stachowicz A, Pandey R, Sundararaman N, Venkatraman V, Van Eyk JE, Fert-Bober J. Protein arginine deiminase 2 (PAD2) modulates the polarization of THP-1 macrophages to the anti-inflammatory M2 phenotype. J Inflame. 2022;19:20.","journal-title":"J Inflame"},{"key":"869_CR15","doi-asserted-by":"publisher","first-page":"795","DOI":"10.4049\/jimmunol.1800720","volume":"203","author":"N Mishra","year":"2019","unstructured":"Mishra N, Schwertner L, Sams K, et al. Cutting edge: protein arginine deiminases 2 and 4 regulate NLRP3 inflammasome\u2013dependent IL-1\u03b2 maturation and ASC speck formation in macrophages[J]. J Immunol. 2019;203:795\u2013800.","journal-title":"J Immunol"},{"key":"869_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1131178","volume":"14","author":"C Wang","year":"2023","unstructured":"Wang C, Xiong Y, Bao C, et al. Antibacterial and anti-biofilm activity of cadazolid against Staphylococcus aureus clinical isolates from China. Front Microb. 2023;14:1131178.","journal-title":"Front Microb"},{"key":"869_CR17","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00213-21","volume":"59","author":"R Humphries","year":"2021","unstructured":"Humphries R, Bobenchik AM, Hindler JA, Schuetz AN. Overview of changes to the clinical and laboratory standards Institute Performance Standards for Antimicrobial Susceptibility Testing, M100, 31st Edition. J Clin Microbiol. 2021;59:e0021321.","journal-title":"J Clin Microbiol"},{"key":"869_CR18","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.00074-22","volume":"61","author":"VM Pierce","year":"2023","unstructured":"Pierce VM, Bhowmick T, Simner PJ. Guiding antimicrobial stewardship through thoughtful antimicrobial susceptibility testing and reporting strategies: an updated approach in 2023. J Clin Microbiol. 2023;61:e0007422.","journal-title":"J Clin Microbiol"},{"key":"869_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.970901","volume":"13","author":"X Liu","year":"2022","unstructured":"Liu X, Xiong Y, Shi Y, et al. In vitro, the activities of licochalcone A against planktonic cells and biofilm of Enterococcus faecalis. Front Microbiol. 2022;13:970901.","journal-title":"Front Microbiol"},{"key":"869_CR20","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1093\/jac\/dkg160","volume":"51","author":"C Jacqueline","year":"2003","unstructured":"Jacqueline C, Caillon J, Le Mabecque V, et al. In vitro activity of linezolid alone and in combination with gentamicin, vancomycin, or rifampicin against methicillin-resistant Staphylococcus aureus by time-kill curve methods. J Antimicrob Chemother. 2003;51:857\u201364.","journal-title":"J Antimicrob Chemother"},{"key":"869_CR21","doi-asserted-by":"publisher","first-page":"2914","DOI":"10.3390\/ijms24032914","volume":"24","author":"IP S\u00e6b\u00f8","year":"2023","unstructured":"S\u00e6b\u00f8 IP, Bj\u00f8r\u00e5s M, Franzyk H, Helgesen E, Booth JA. Optimization of the hemolysis assay for the assessment of cytotoxicity. Int J Mol Sci. 2023;24:2914.","journal-title":"Int J Mol Sci"},{"key":"869_CR22","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.2174\/1389201017666160808160513","volume":"17","author":"A Adan","year":"2016","unstructured":"Adan A, Kiraz Y, Baran Y. Cell proliferation and cytotoxicity assays. Curr Pharm Biotechnol. 2016;17:1213\u201321.","journal-title":"Curr Pharm Biotechnol"},{"key":"869_CR23","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ads3844","volume":"11","author":"Y Zhu","year":"2025","unstructured":"Zhu Y, Xu W, Chen W, et al. Self-assembling peptide with dual function of cell penetration and antibacterial as a nano weapon to combat intracellular bacteria. Sci Adv. 2025;11:eads3844.","journal-title":"Sci Adv"},{"key":"869_CR24","doi-asserted-by":"publisher","first-page":"5350","DOI":"10.3390\/ijms24065350","volume":"24","author":"VA Duong","year":"2023","unstructured":"Duong VA, Lee H. Bottom-up proteomics: advancements in sample preparation. Int J Mol Sci. 2023;24:5350.","journal-title":"Int J Mol Sci"},{"key":"869_CR25","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1093\/rheumatology\/keh414","volume":"44","author":"X Chang","year":"2005","unstructured":"Chang X, Yamada R, Suzuki A, et al. Localization of peptidylarginine deiminase 4 (PADI4) and citrullinated protein in synovial tissue of rheumatoid arthritis[J]. Rheumatology. 2005;44:40\u201350.","journal-title":"Rheumatology"},{"key":"869_CR26","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2024.2321981","volume":"13","author":"J Zheng","year":"2024","unstructured":"Zheng J, Liu X, Xiong Y, et al. AMXT-1501 targets membrane phospholipids against Gram-positive and -negative multidrug-resistant bacteria. Emerg Microbes Infect. 2024;13:2321981.","journal-title":"Emerg Microbes Infect"},{"key":"869_CR27","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s00284-024-04001-3","volume":"82","author":"J Huang","year":"2024","unstructured":"Huang J, Xu Z, He P, et al. Repurposing TAK-285 as an antibacterial agent against multidrug-resistant Staphylococcus aureus by targeting cell membrane. Curr Microbiol. 2024;82:8.","journal-title":"Curr Microbiol"},{"key":"869_CR28","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s12866-024-03377-3","volume":"24","author":"X Liu","year":"2024","unstructured":"Liu X, Xiong Y, Peng R, et al. Antibacterial activity, and mechanisms of D-3263 against Staphylococcus aureus. BMC Microbiol. 2024;24:224.","journal-title":"BMC Microbiol"}],"container-title":["The Journal of Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41429-025-00869-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41429-025-00869-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41429-025-00869-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T23:06:50Z","timestamp":1767654410000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41429-025-00869-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,9]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["869"],"URL":"https:\/\/doi.org\/10.1038\/s41429-025-00869-w","relation":{},"ISSN":["0021-8820","1881-1469"],"issn-type":[{"type":"print","value":"0021-8820"},{"type":"electronic","value":"1881-1469"}],"subject":[],"published":{"date-parts":[[2025,10,9]]},"assertion":[{"value":"13 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Approval of ethics and permission for participation. All techniques were conducted in accordance with applicable norms and regulations, authorized by the Ethics Committee of Shenzhen Nanshan People\u2019s Hospital, and in compliance with the Helsinki Declaration of 1964 and its later revisions or similar ethical standards. All experimental techniques involving human volunteers received approval from the Institutional Ethics Committee of Shenzhen Nanshan People\u2019s Hospital. Bacterial strains were obtained in accordance with national standards for the regular clinical therapy of patients in China. Consequently, informed permission was not acquired, and a waiver of informed consent was sanctioned by the Institutional Ethics Committee of Shenzhen Nanshan People\u2019s Hospital.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}